Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

The Prize-winners are universities and colleges who have been recognised for ground-breaking work and pioneering research in a wide range of disciplines including science, engineering, education, the humanities, the environment and medicine. 

Among those honoured was Oxford University whose efforts delivered vitally important design and creation of a COVID-19 vaccine. This work was notably completed at an unprecedented speed and helped reduce loss of life worldwide from coronavirus.

In a period where COVID-19 and climate change have become the most prominent issues of our time, the final list of Prize-winners reflects the strong contribution of universities and colleges in these areas. 

Patrick Grant, Pro Vice Chancellor (Research) Oxford University said, 'Oxford tackled COVID-19 using all of our capabilities to understand and fight the pandemic. We worked across all disciplines, departments and teams to develop vaccines, to repurpose drugs, to support the prediction of future outbreaks, to inform public health and to develop diagnostic tools.'

He added, 'This prestigious award is a testament to the dedication, resilience and commitment of Oxford University’s research students and research staff at all career stages. We can all be proud of our efforts and achievements during a very difficult time.’

Read the full story on the University of Oxford website.

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations to Professor Gero Miesenböck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology

The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.